SCHEMBL14639748

SCHEMBL14639748

O=CC1C=CC=CC1C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882713 0.78
SCHEMBL12198922 0.78
SCHEMBL15699984 0.78
SCHEMBL18831002 0.78
SCHEMBL16229919 0.69
SCHEMBL2797217 0.69
SCHEMBL14325291 0.68
SCHEMBL28051021 0.67
SCHEMBL28196730 0.67
SCHEMBL11054232 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022094609-A1 OLIGONUCLEOTIDE-BASED THERAPEUTICS AND USES THEREOF SPEER TOD (US) 2022-05-05 WO disclosed
US-9259000-B2 Auxin biosynthesis inhibitor RIKEN (JP) 2016-02-16 US disclosed
US-20140031230-A1 AUXIN BIOSYNTHESIS INHIBITOR Riken Public University Corporation Yokohama City University 2014-01-30 US disclosed
WO-2007001283-A2 CHEMICAL SYNTHESIS OF LOW MOLECULAR WEIGHT POLYGLUCOSAMINES AND POLYGALACTOSAMINES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2007-01-04 WO disclosed